ctDNA evaluation may play a prognostic role in stage III colon cancer treated with celecoxib

Addition of trastuzumab to chemo does not provide significant survival benefit in HER-2 positive stomach cancer

Low-dose aspirin can reduce recurrence rates in colorectal cancer patients with PI3K pathway alterations

Nivolumab plus ipilimumab shows superior efficacy in metastatic colorectal compared to nivolumab monotherapy

Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population

Everolimus plus lanreotide might be a new standard treatment in the first-line setting for grade 1/2 GEP-NETs